1. Boston Consulting Group. A Revolution in R&D: How Genomics and Genetics are Transforming the Biopharmaceutical Industry. (Boston Consulting Group, Boston, Massachusetts, 2001).
2. DiMasi, J., Hansen, R. W. & Grabowski, H. G. The price of innovation: new estimates of drug development costs. J. Health Econ. 22, 151–185 (2003).
3. Relman, A. S. & Angell, M. America's other drug problem. The New Republic 16, 27–41 (2002).
4. Public Citizen. America's Other Drug Problem: a Briefing Book on the Rx Drug Debate (Public Citizen, Washington DC, 2002).
5. Grabowski, H. G. & Vernon, J. M. Returns to R&D on new introductions in the 1980s. J. Health Econ. 13, 383–406 (1994).